title: The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer.
abstract: Although drug-eluting stents (DESs) have become the most effective means of treating coronary artery disease, safety concerns regarding their thrombogenicities remain to be surmounted. Here, we report on a novel type of DES capable of preventing restenosis and thrombosis. The DES was prepared by coating a bare metal stent with echinomycin (an anti-proliferative drug) in polyurethane by a spray drying method. Hydrophobic heparinized polymer was then topcoated onto stent over echinomycin/PU layer by dipping to improve hemocompatibility. The two-layered stent was characterized regarding surface and cross-sectional morphology, drug release pattern, platelet adhesion in vitro, and restenosis in vivo. It was found that the heparin topcoat acts as a diffusion barrier that allows the controlled release of drug in a sustained manner. Also, the heparin coated layer effectively reduced platelet adhesion, indicating excellent hemocompatibility. From the animal test using pigs, it was evident that the developed DESs can minimize neointimal proliferation and thrombus formation. The devised hydrophobic heparinized polymer-coated DES effectively reduced both restenosis and thrombosis, suggesting that they have potential as tools for the treatment of coronary artery diseases.
authors.affiliation: Department of Chemical Engineering, Chungju National University, Chungbuk 380-702, South Korea.
authors.forename: Yong-Kyu
authors.initials: YK
authors.lastname: Lee
authors.forename: Jae
authors.initials: J
authors.lastname: Hyung Park
authors.forename: Hyun
authors.initials: H
authors.lastname: Tae Moon
authors.forename: Dong
authors.initials: D
authors.lastname: Yun Lee
authors.forename: Jung
authors.initials: J
authors.lastname: Han Yun
authors.forename: Youngro
authors.initials: Y
authors.lastname: Byun
mesh_terms: D000818:Animals; D020099:Coated Materials, Biocompatible; D023903:Coronary Restenosis / Q000188:drug therapy*; D016503:Drug Delivery Systems; D004448:Echinomycin / Q000008:administration & dosage / Q000494:pharmacology*; D006131:Growth Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D006493:Heparin; D010974:Platelet Aggregation / Q000187:drug effects; D011108:Polymers; D011817:Rabbits; D015607:Stents; D013552:Swine; D013927:Thrombosis / Q000188:drug therapy*
chemical_list: D020099:Coated Materials, Biocompatible; D006131:Growth Inhibitors; D011108:Polymers; D004448:Echinomycin; D006493:Heparin